Granules India rises on USFDA nod for oral drug Glycopyrrolate

Granules India added 1.77% to Rs 673.95 after the US Food and Drug Administration (FDA) approved its abbreviated new drug application (ANDA) for Glycopyrrolate Oral Solution.